Document Type : Original Article


1 Department of Poultry Health and Diseases, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

2 Department of Avian Diseases Research and Diagnostics, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization, Karaj, Iran

3 Department of Avian Diseases Research and Diagnostics, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran


Newcastle disease virus (NDV) is considered one of the most devastating avian viral patho-gens affecting the avian population, and it causes a significant economic burden on the poultry industry worldwide. The study aimed to gain deeper understanding of the molecular and phylogenetic analyses of the complete hemagglutinin-neuraminidase (HN) coding region among NDV isolates. The samples were obtained from different parts of Iran from July 2017 to February 2020, were used for phylogenic analysis in this study. The results confirmed the predominance of sub-genotype VII.1.1, previously known as sub-genotype VIIL, which is circulating in commercial broiler farms of Iran. Identification of (a) an additional N-glycosylation site (NIS) at position 144; (b) mutations S315P and I369V which are related to increasing the viral thermostability; (C) cysteine residues at positions 123; (d) amino acid substitutions in the HN antigenic sites, especially the mutations I514V and E347Q, as well as the other mutant within HN binding sites of the VII.1.1 sub-genotype, suggests the idea that this new sub-genotype of NDV may possess a high level of pathogenicity and virulence compared to other NDV sub-genotypes. In conclusion, the results indicate the presence of an additional NIS at position 144, which may alter the virulence of the isolates. Furthermore, the presence of the thermostable mutations (S315P and I369V) and the other amino acid substitutions among the VII.1.1 sub-genotype isolates may have an impact on the vaccine immunity against this new NDV sub-genotype.


Main Subjects

  1. Dortmans JC, Koch G, Rottier PJ, et al. Virulence of Newcastle disease virus: what is known so far? Vet Res 2011; 42(1): 122. doi: 10.1186/1297-9716-42-122.
  2. Dimitrov KM, Abolnik C, Afonso CL, et al. Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus. Infect Genet Evol 2019; 74: 103917. doi: 10.1016/j.meegid. 2019.103917.
  3. Karsunke J, Heiden S, Murr M, et al. W protein expression by Newcastle disease virus. Virus Res 2019; 263: 207-216.
  4. Molouki A, Mehrabadi MHF, Bashashati M, et al. NDV subgenotype VII (L) is currently circulating in commercial broiler farms of Iran, 2017-2018. Trop Anim Health Prod 2019; 51(5): 1247-1252.
  5. Sabouri F, Vasfi Marandi M, Bashashati M. Characterization of a novel VIIl sub-genotype of Newcastle disease virus circulating in Iran. Avian Pathol 2018; 47(1): 90-99.
  6. Huang Z, Panda A, Elankumaran S, et al. The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence. J Virol 2004; 78(8): 4176-4184.
  7. Lamb RA, Jardetzky TS. Structural basis of viral invasion: lessons from paramyxovirus F. Curr Opin Struct Biol 2007; 17(4): 427-436.
  8. Estevez C, King DJ, Luo M, et al. A single amino acid substitution in the haemagglutinin–neuraminidase protein of Newcastle disease virus results in increased fusion promotion and decreased neuraminidase activities without changes in virus pathotype. J Gen Virol 2011; 92(Pt 3): 544-551.
  9. Haji-Abdolvahab H, Ghalyanchilangeroudi A, Bahonar A, et al. Prevalence of avian Influenza, Newcastle disease, and infectious bronchitis viruses in broiler flocks infected with multifactorial respiratory diseases in Iran, 2015-2016. Trop Anim Health Prod 2019; 51(3): 689-695.
  10. Newcastle disease. In: manual of diagnostic tests and vaccines for terrestrial animals. 7th ed. Paris, France: World Organization for Animal Health 2012: 555-573.
  11. Kumar S, Stecher G, Tamura K. MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 2016; 33(7): 1870-1874.
  12. Kumar S, Stecher G, Li M, et al. MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 2018; 35(6): 1547-1549.
  13. Diel DG, da Silva LH, Liu H, et al. Genetic diversity of avian paramyxovirus type 1: proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes. Infect Genet Evol 2012; 12(8): 1770-1779.
  14. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4(4): 406-425.
  15. Miller PJ, Haddas R, Simanov L, et al. Identification of new sub-genotypes of virulent Newcastle disease virus with potential panzootic features. Infect Genet Evol 2015; 29: 216-229.
  16. Malirat V, de Barros JJ, Bergmann IE, et al. Phylogenetic analysis of foot-and-mouth disease virus type O re-emerging in free areas of South America. Virus Res 2007; 124(1-2): 22-28.
  17. Zhang YY, Shao MY, Yu XH, et al. Molecular characterization of chicken-derived genotype VIId Newcastle disease virus isolates in China during 2005-2012 reveals a new length in hemagglutinin–neuraminidase. Infect Genet Evol 2014; 21: 359-366.
  18. Simmons GC. The isolation of Newcastle disease virus in Queensland. Aust Vet J 1967; 43(1): 29-30.
  19. Ruan B, Zhang X, Zhang C, et al. Residues 315 and 369 in HN protein contribute to the thermostability of Newcastle disease virus. Front Microbiol 2020; 11: 560482. doi: 10.3389/fmicb.2020.560482.
  20. Bustamante JP, Bonamore A, Nadra AD, et al. Molecular basis of thermal stability in truncated (2/2) hemoglobins. Biochim Biophys Acta 2014; 1840(7): 2281-2288.
  21. Prajapati RS, Das M, Sreeramulu S, et al. Thermodynamic effects of proline introduction on protein stability. Proteins 2007; 66(2): 480-491.
  22. Omony JB, Wanyana A, Mugimba KK, et al. Disparate thermostability profiles and HN gene domains of field isolates of Newcastle disease virus from live bird markets and waterfowl in Uganda. Virol J 2016; 13: 103. doi: 10.1186/s12985-016-0560-0.
  23. McGinnes LW, Morrison TG. The role of individual oligosaccharide chains in the activities of the HN glycoprotein of Newcastle disease virus. Virology 1995; 212(2): 398-410.
  24. Li S, Schulman J, Itamura S, et al. Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. J Virol 1993; 67(11): 6667-6673.
  25. Ward AC, de Koning-Ward TF. Changes in the hemagglutinin gene of the neurovirulent influenza virus strain A/NWS/33. Virus Genes 1995; 10(2): 179-183.
  26. Panda A, Elankumaran S, Krishnamurthy S, et al. Loss of N-linked glycosylation from the hemagglutinin-neuraminidase protein alters virulence of Newcastle disease virus. J Virol 2004; 78(10): 4965-4975.
  27. Iorio RM, Bratt MA. Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sites. J Immunol 1984; 133(4): 2215-2219.
  28. Seal BS. Nucleotide and predicted amino acid sequence analysis of the fusion protein and hemagglutinin-neuraminidase protein genes among Newcastle disease virus isolates. phylogenetic relationships among the Paramyxovirinae based on attachment glycoprotein sequences. Funct Integr Genomics 2004; 4(4): 246-257.
  29. Zhu J, Hu S, Xu H, et al. Characterization of virulent Newcastle disease viruses from vaccinated chicken flocks in Eastern China. BMC Vet Res 2016; 12(1): 113. doi: 10.1186/s12917-016-0732-6.
  30. Cho SH, Kwon HJ, Kim TE, et al. Characterization of a recombinant Newcastle disease virus vaccine strain. Clin Vaccine Immunol 2008; 15(10): 1572-1579.
  31. Hu S, Wang T, Liu Y, et al. Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein. Vet Microbiol 2010; 140(1-2): 92-97.
  32. Jorgensen ED, Collins PL, Lomedico PT. Cloning and nucleotide sequence of Newcastle disease virus hemagglutinin-neuraminidase mRNA: identification of a putative sialic acid binding site. Virology 1987; 156(1): 12-24.
  33. Zaitsev V, von Itzstein M, Groves D, et al. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: Implications for fusion. J Virol 2004; 78(7): 3733-3741.
  34. Mahon PJ, Mirza AM, Iorio RM. Role of the two sialic acid binding sites on the Newcastle disease virus HN protein in triggering the interaction with the F protein required for the promotion of fusion. J Virol 2011; 85(22): 12079-12082.
  35. Nishikawa K, Morishima T, Toyoda T, et al. Topological and operational delineation of antigenic sites on the HN glycoprotein of Newcastle disease virus and their structural requirements. J Virol 1986; 60(3): 987-993.
  36. Sakaguchi T, Toyoda T, Gotoh B, et al. Newcastle disease virus evolution: I. multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene. Virology 1989; 169(2): 260-272.
  37. Miller PJ, Decanini EL, Afonso CL. Newcastle disease: evolution of genotypes and the related diagnostic challenges. Infect Genet Evol 2010; 10(1): 26-35.